Market Overview

The global Surrogacy Market was valued at USD 204.6 Million in 2025 and is projected to reach USD 329.2 Million by 2034. The market is expected to grow at a compound annual growth rate (CAGR) of 5.43% during the forecast period 2026-2034. Growth is driven by rising infertility, advances in assisted reproductive technology, supportive legal frameworks, and increasing societal acceptance.

Study Assumption Years

• Base Year: 2025
• Historical Year/Period: 2020-2025
• Forecast Year/Period: 2026-2034

Surrogacy Market Key Takeaways

• The global surrogacy market size was USD 204.6 Million in 2025.
• The market is projected to grow at a CAGR of 5.43% during 2026-2034.
• The forecast period for the market is from 2026 to 2034.
• The surrogacy market growth is mainly driven by increasing infertility rates and growing social acceptance.
• Legal developments in various countries with clear rules have significantly contributed to market expansion.
• Technological advancements like improvements in IVF treatments enhance surrogacy success rates.
• Economic factors, including affordable surrogacy services in some regions, support market growth.

Sample Request Link: 

https://www.imarcgroup.com/surrogacy-market/requestsample

Market Growth Factors

The surrogacy market is driven by the rising global incidence of infertility, growing public knowledge and acceptance of surrogacy as an assisted reproductive technology option, governments' willingness to allow surrogacy contracts in various countries and to create a predictable legal system and protections for surrogacy participants, and increasing IVF technology efficacy. Increased acceptance of LGBTQ+ rights, as well as of the idea that homosexual couples are entitled to start a family, has also contributed towards the growth of the market, along with lower cost surrogacy in certain countries.

Market trends: Global surrogacy condemns trends such as the greater acceptance of gestational surrogacy, which makes up more than 90% of surrogacy, due to the genetic separation of surrogate and child, the success of ART, and decreased uncertainty in the legality of surrogacy in a country. Other market factors are differences in ethical, regulatory and legal practices globally and the rise of fertility tourism.

Acceptance of families with children born via surrogacy reduces cultural barriers and promotes demand. Some studies find that in some countries, professionals, such as lawyers, increasingly have positive attitudes. IVF with ICSI, pre-implantation genetic diagnosis, and embryo selection have high success rates. The success rate for gestational surrogacy varies and is from 30% to 60% per embryo transfer. As reproductive technologies become safer and more effective, there are growing markets for people with infertility and same-sex couples to start a family via surrogacy.

Market Segmentation

By Type:

• Gestational Surrogacy: Dominates the market; involves surrogates carrying pregnancies conceived from the eggs and sperm of intended parents or donors, reducing genetic connection and related legal challenges. This segment benefits individuals with reproductive issues, same-sex couples, and those seeking genetic diversity. Enhancements in IVF accuracy boost success rates.
• Traditional Surrogacy: Included but less dominant segment.

By Technology:

• IVF with ICSI: Holds the largest market share; a sophisticated assisted reproductive technology injecting a single sperm into an egg directly to overcome male infertility. It allows surrogacy services to address complex fertility problems and improves success rates, making surrogacy a trusted option.
• IVF without ICSI
• Intrauterine Insemination

By Service Provider:

• Fertility Clinics: Largest segment; key drivers providing advanced reproductive technologies, full medical assessments, treatment plans, and continuous monitoring throughout surrogacy. They collaborate with surrogacy agencies and legal experts, facilitating smooth processes.
• Hospitals
• Others

Regional Insights

North America dominates the global surrogacy market due to its favorable legal and social environment. The region's supportive regulatory framework ensures safety for intended parents and surrogates. Advanced medical facilities and skilled personnel in assisted reproductive technologies, combined with high societal acceptance, attract domestic and international clientele. The multi-ethnic population and evolving family perceptions further promote surrogacy services in this region.

Recent Developments & News

• In June 2021, Circle Surrogacy & Egg Donation launched the "A Lifetime of Pride and Joy" campaign to raise awareness about fertility care accessibility for the LGBTQ+ community, promoting family equality.
• In June 2023, AHH's Nova IVF Fertility announced plans to establish a network of 100 fertility centers across India within four years to provide advanced, accessible care.
• In October 2022, Ovation Fertility partnered with Genomic Prediction to enhance genetic testing capabilities in fertility and family planning, offering deeper genetic insights to intended parents.

Key Players

• Bourn Hall Fertility Clinic
• Care Fertility
• Circle Surrogacy
• Extraordinary Conceptions
• Growing Generations
• Houston Fertility Center
• IVIRMA Global
• Kindbody
• Max Healthcare
• New Hope Fertility Clinic
• Nova IVF
• Ovation Fertility

Request For Customization:

https://www.imarcgroup.com/request?type=report&id=5298&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302